These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 77357)

  • 1. Humoral and cellular immune response of prostatic cancer patients to cytomegalovirus-related antigens.
    Sanford EJ; Geder L; Dagen JE; Laychock A; Rohner TJ; Rapp F
    J Surg Res; 1978 May; 24(5):404-8. PubMed ID: 77357
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune response of prostatic cancer patients to cytomegalovirus-infected and -transformed human cells.
    Laychock AM; Geder L; Sanford EJ; Rapp F
    Cancer; 1978 Oct; 42(4):1766-71. PubMed ID: 81717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte reactivity against virally transformed cells in patients with urologic cancer.
    Sanford EJ; Dagen JE; Geder L; Rohner TJ; Rapp F
    J Urol; 1977 Nov; 118(5):809-10. PubMed ID: 72168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum antibody levels of cytomegalovirus, herpes simplex type I and adenovirus in patients with benign or malignant prostatic neoplasms].
    Peker AF; Erkan I; Ozen HA; Ustaçelebi S; Ozdemir T
    Mikrobiyol Bul; 1986 Jul; 20(3):165-75. PubMed ID: 2436029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis: cellular and humoral immune responses to several viruses.
    Fuccillo DA; Madden DL; Castellano GA; Uhlig L; Traub RG; Mattson J; Krezlewicz A; Sever JL
    Neurology; 1978 Jun; 28(6):613-5. PubMed ID: 206860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus and cancer of the prostate: in vitro transformation of human cells.
    Geder L; Sanford EJ; Rohner TJ; Rapp F
    Cancer Treat Rep; 1977; 61(2):139-46. PubMed ID: 68820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular immune response to virus-specific antigen in hamsters bearing isografts of cytomegalovirus-transformed cells.
    Murasko DM; Lausch RN
    Int J Cancer; 1974 Oct; 14(4):451-60. PubMed ID: 4142468
    [No Abstract]   [Full Text] [Related]  

  • 8. [Humoral and cellular immunity in prostatic adenocarcinoma].
    Pérez Herrero F; Alfonso Sánchez M; Gutierrez Mínguez E; Urrutia Avisrror M; Montero Gómez J
    Actas Urol Esp; 1983; 7(6):433-6. PubMed ID: 6670612
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence for the association of cytomegalovirus with carcinoma of the prostate.
    Sanford EJ; Geder L; Laychock A; Rohner TJ; Rapp F
    J Urol; 1977 Nov; 118(5):789-92. PubMed ID: 199749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for nuclear antigens in cytomegalovirus-transformed human cells.
    Geder L; Rapp F
    Nature; 1977 Jan; 265(5590):184-6. PubMed ID: 189206
    [No Abstract]   [Full Text] [Related]  

  • 11. HCMV envelope antigens induce both humoral and cellular immunity in guinea pigs.
    Furukawa T; Gonczol E; Starr S; Tolpin MD; Arbeter A; Plotkin SA
    Proc Soc Exp Biol Med; 1984 Feb; 175(2):243-50. PubMed ID: 6320210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological studies with hamster cells transformed by cytomegalovirus and herpes simplex virus type 1.
    Lausch RN; Murasko DM; Jones C; Hay KA
    IARC Sci Publ (1971); 1975; (11 Pt 1):315-21. PubMed ID: 190134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic aspects of the prostate.
    Lubaroff DM; Reynolds CW; Canfield L; McElligott D; Feldbush T
    Prostate; 1981; 2(3):233-48. PubMed ID: 6170966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of sera from SV40-immunized and tumor-bearing hosts for blocking activity and antibody-dependent cellular cytotoxicity.
    Lausch RN; Sofranko J; Prather SO
    J Immunol; 1975 Sep; 115(3):682-7. PubMed ID: 168264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of specific cellular and humoral immune responses in children immunized with live rubella virus vaccine.
    Steele RW; Hensen SA; Vincent MM; Fuccillo DA; Bellanti JA
    J Infect Dis; 1974 Nov; 130(5):449-53. PubMed ID: 4472899
    [No Abstract]   [Full Text] [Related]  

  • 16. Spleen-cell cytotoxicity for cytomegalovirus-transformed cells. II. Inhibition by cytomegalovirus antiserum.
    Murasko DM; Lausch RN
    Int J Cancer; 1975 Jul; 16(1):24-32. PubMed ID: 170214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpesviruses and prostate carcinogenesis.
    Geder L; Rapp F
    Arch Androl; 1980 Feb; 4(1):71-8. PubMed ID: 6153521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocytotoxic antibodies in prostatic cancer.
    Ablin RJ; Baird WM
    JAMA; 1971 Jun; 216(12):2015. PubMed ID: 4103257
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell-mediated immunity in prostatic cancer and its diagnostic relevancy.
    Ablin RJ; Guinan PD; Bhatti RA
    Eur J Cancer Clin Oncol; 1983 Apr; 19(4):467-71. PubMed ID: 6190657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenocarcinoma R-3327 of the Copenhagen rat as a suitable model for immunological studies of prostate cancer.
    Lopez DM; Voigt W
    Cancer Res; 1977 Jul; 37(7 Pt 1):2057-61. PubMed ID: 301055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.